MarketsandMarkets Biomarker and Companion Diagnostics Conference
Share this event
Join the community at the Biomarker and Companion Diagnostics Conference to be held this October in London
Biomarker is constantly evolving as the latent for the development of innovative drugs and diagnostic assays for early detection of disease. The major developments are witnessed in immune therapies where breakthroughs will be appearing soon.
The conference, which will take place on 3 and 4 October 2019, will address the gaps between early stage biomarker development and the commercialization stage of biomarkers. Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to the clinical translation of biomarkers.